Figures & data
Table 1. Uptake studies of biotin in various cell lines.
Table 2. Applications of biotin in the development of drugs and diagnostics.
Said HM, Redha R, Nylander W. A carrier-mediated, Na+ gradient-dependent transport for biotin in human intestinal brush-border membrane vesicles. Am J Physiol. 1987;253(5 Pt 1):G631–G636. Ma TY, Dyer DL, Said HM. Human intestinal cell line Caco-2: a useful model for studying cellular and molecular regulation of biotin uptake. Biochim Biophys Acta. 1994;1189(1):81–88. Luo S, Kansara VS, Zhu X, Mandava NK, Pal D, Mitra AK. Functional characterization of sodium-dependent multivitamin transporter in MDCK-MDR1 cells and its utilization as a target for drug delivery. Mol Pharm. 2006;3(3):329–339. Kansara V, Luo S, Balasubrahmanyam B, Pal D, Mitra AK. Biotin uptake and cellular translocation in human derived retinoblastoma cell line (Y-79): a role of hSMVT system. Int J Pharm. 2006;312(1–2):43–52. Vadlapudi AD, Vadlapatla RK, Pal D, Mitra AK. Biotin uptake by T47D breast cancer cells: functional and molecular evidence of sodium-dependent multivitamin transporter (SMVT). Int J Pharm. 2013;441(1–2):535–543. Wang W, Ackermann D, Mehlich AM, König S. False labelling due to quenching failure of N-hydroxy-succinimide-ester-coupled dyes. Proteomics. 2010;10(7):1525–1529. Jung D, Maiti S, Lee JH, Lee JH, Kim JS. Rational design of biotin–disulfide–coumarin conjugates: a cancer targeted thiol probe and bioimaging. Chem Commun. 2014;50(23):3044–3047. Maiti S, Park N, Han JH, Jeon HM, Lee JH, Bhuniya S, Kang C, Kim JS. Gemcitabine–coumarin–biotin conjugates: a target specific theranostic anticancer prodrug. J Am Chem Soc. 2013;135(11):4567–4572. Bhuniya S, Maiti S, Kim EJ, Lee H, Sessler JL, Hong KS, Kim JS. An activatable theranostic for targeted cancer therapy and imaging. Angew Chem Int Ed Engl. 2014;53(17):4469–4474. Chen S, Zhao X, Chen J, Chen J, Kuznetsova L, Wong SS, Ojima I. Mechanism-based tumor-targeting drug delivery system. Validation of efficient vitamin receptor-mediated endocytosis and drug release. Bioconjug Chem. 2010;21(5):979–987. Hu W, Fang L, Hua W, Gou S. Biotin–Pt (IV)–indomethacin hybrid: a targeting anticancer prodrug providing enhanced cancer cellular uptake and reversing cisplatin resistance. J Inorg Biochem. 2017;175:47–57. Zhang X, Qi J, Lu Y, He W, Li X, Wu W. Biotinylated liposomes as potential carriers for the oral delivery of insulin. Nanomedicine. 2014;10(1):167–176. Cetin M, Youn YS, Capan Y, Lee KC. Preparation and characterization of salmon calcitonin–biotin conjugates. AAPS PharmSciTech. 2008;9(4):1191–1197. Zhu W, Song Z, Wei P, Meng N, Teng F, Yang F, Liu N, Feng R. Y-shaped biotin-conjugated poly (ethylene glycol)–poly (epsilon-caprolactone) copolymer for the targeted delivery of curcumin. J Colloid Interface Sci. 2015;443:1–7. Shi JF, Wu P, Jiang ZH, Wei XY. Synthesis and tumor cell growth inhibitory activity of biotinylated annonaceous acetogenins. Eur J Med Chem. 2014;71:219–228. Heo DN, Yang DH, Moon HJ, Lee JB, Bae MS, Lee SC, Lee WJ, Sun IC, Kwon IK. Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy. Biomaterials. 2012;33(3):856–866.